Showing results (351-360 of 687) with videos related to
Sort By:
Pageof 69
Alimentary Pharmacology & Therapeutics|February 28, 2002
Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver diseaseG Marino, V K Rustgi, G Salzberg, et al.Cancer Journal (Sudbury, Mass.)|January 9, 2007
Clinical trial resources on the internet must be designed to reach underrepresented minoritiesJohn J Wilson, Rosemarie Mick, S Jack Wei, et al.Plos One|March 15, 2024
The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver DiseaseMohamed I Elsaid, John F P Bridges, Khalid Mumtaz, et al.Case Reports in Hepatology|November 30, 2019
Hepatic Silicone Granulomas Secondary to Ruptured Breast Implants: A Report of Two CasesRachel Hudacko, Kapil Anand, Ronald Gordon, et al.Cancer Research Communications|May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric CancerNaryan Rustgi, Sharon Wu, Timothy Samec, et al.Journal of Proteome Research|February 10, 2009
Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discoveryKenneth H Yu, Colin G Barry, David Austin, et al.Transplantation|May 8, 1999
Portopulmonary hypertension and the liver transplant candidateP C Kuo, J S Plotkin, S Gaine, et al.Oncogene|February 2, 1999
Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epitheliumT D Jenkins, A Mueller, R Odze, et al.Journal of Proteome Research|September 23, 2009
Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancerKannan Rangiah, Montri Tippornwong, Vineet Sangar, et al.Gastroenterology|December 8, 2016
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset DiabetesBen Boursi, Brian Finkelman, Bruce J Giantonio, et al.Pageof 69